Abstract |
Flavopiridol is a cyclin-dependent kinase inhibitor that induces cell cycle arrest, apoptosis, and clinical responses in selected patients with acute myeloid leukemia (AML). A better understanding of the molecular pathways targeted by flavopiridol is needed to design optimal combinatorial therapy. Here, we report that in vivo administration of flavopiridol induced expression of the BCL-2 anti-apoptotic gene in leukemic blasts from adult patients with refractory AML. Moreover, flavopiridol repressed the expression of genes encoding oncogenic transcription factors (HMGA1, STAT3, E2F1) and the major subunit of RNA Polymerase II. Our results provide mechanistic insight into the cellular pathways targeted by flavopiridol. Although further studies are needed, our findings also suggest that blocking anti-apoptotic pathways could enhance cytotoxicity with flavopiridol.
|
Authors | Dwella M Nelson, Biju Joseph, Joelle Hillion, Jodi Segal, Judith E Karp, Linda M S Resar |
Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 52
Issue 10
Pg. 1999-2006
(Oct 2011)
ISSN: 1029-2403 [Electronic] United States |
PMID | 21728742
(Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- Flavonoids
- Piperidines
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins c-bcl-2
- Transcription Factors
- alvocidib
- RNA Polymerase II
|
Topics |
- Adult
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- Blast Crisis
(drug therapy)
- Female
- Flavonoids
(administration & dosage, pharmacology, therapeutic use)
- Humans
- Leukemia, Myeloid, Acute
(drug therapy, pathology)
- Male
- Middle Aged
- Oncogenes
- Piperidines
(administration & dosage, pharmacology, therapeutic use)
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins c-bcl-2
(biosynthesis, drug effects)
- RNA Polymerase II
(drug effects)
- Transcription Factors
(antagonists & inhibitors)
- Young Adult
|